Table 1. Prevalence of metabolic syndrome in selected developed countries.
| Reference | Criteria used | Study design | N | Age,a years | Country | MetS prevalence | |
| Male % | Female % | ||||||
| Aguilar et al10 | Modified NCEP | NHANES, 2003-12; Cross-sectional | 1,931 | ≥20 | United States (MetS prevalence per ethnic group: African American, 33.0%; Hispanic, 35.0%; Non-Hispanic Whites, 33.0%) | 30.3 | 35.6 |
| Khan and Jackson11 | Harmonized | Cross-sectional (urban) | 1,403 | 20-68 | United States (South Asian Americans) | 47.0 | 54.0 |
| Tillin et al12 | Modified NCEP | Cross-sectional (urban) | 4,860 | 40-69 | United Kingdom | ||
| African Caribbeans | 15.5b | 23.4 b | |||||
| Europeans | 18.4 b | 14.4b | |||||
| South Asians | 28.8 b | 31.8 b | |||||
| Villegas et al13 | Modified NCEP | Cross-sectional (urban) | 890 | 50-69 | Ireland | 21.8 | 21.5 |
| Jeppesen et al14 | Modified NCEP | Cross-sectional (urban) | 2,493 | 41-72 | Denmark | 18.6 | 14.3 |
| Cameron et al15 | IDF | Cross-sectional (population- based) | 6,072 | 50.5 ± 11.7 | Australia | 39.2 | 27.9 |
| Bo et al16 | Modified NCEP | Cross-sectional (urban) | 1,877 | 45-64 | Italy | 24.1 | 23.1 |
a. Age range or mean age of participants as provided by the respective journal articles.
b. Age-adjusted MetS prevalence used.
NHANES, National Health and Nutrition Examination Survey; NCEP, National Cholesterol Education Program; IDF, International Diabetes Federation.